Fietz, S., Diekmann, E., Vos, L. d., Zarbl, R., Hunecke, A., Glosch, A., . . . Dietrich, D. (2024). Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma. Clinical Chemistry, 70(3), 516-528.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Fietz, Simon, et al. "Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma."
Clinical Chemistry 70, no. 3 (2024): 516-528.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Fietz, Simon, et al. "Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma."
Clinical Chemistry, vol. 70, no. 3, 2024, pp. 516-528.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.